LTA and prostate carcinoma: We found that TNF-β was responsible for Id-1-mediated inhibition of prostate cancer cell-mediated osteoblast mineralisation, but was not accountable for Id-1-mediated activation of prostate cancer cell-mediated osteoclast differentiation.